OP Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3M Sell
633,811
-368,694
-37% -$9.64M 0.16% 100
2026
Q1
$28.2M Buy
1,002,505
+372,851
+59% +$9.93M 0.28% 52
2025
Q4
$15.7M Buy
629,654
+15,258
+2% +$385K 0.19% 93
2025
Q3
$15.7M Buy
614,396
+11,811
+2% +$292K 0.2% 89
2025
Q2
$14.6M Buy
602,585
+7,396
+1% +$172K 0.21% 85
2025
Q1
$15.1M Buy
+595,189
New +$15.6M 0.25% 74

Other funds holding PFE

OP Asset Management's PFE Position: Q2 2026 in Review

OP Asset Management reduced its Pfizer (PFE) stake by 37% in Q2 2026, selling an estimated $9.64M and leaving 633,811 shares worth $15.3M. The position accounts for 0.16% of the portfolio, ranked #100.

OP Asset Management first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $28.2M in Q1 2026. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • OP Asset Management held 633,811 shares of Pfizer worth $15.3M as of Q2 2026.
  • OP Asset Management sold 368,694 Pfizer shares in Q2 2026, an estimated $9.64M.
  • Pfizer made up 0.16% of OP Asset Management's portfolio in Q2 2026, its #100 holding.
  • OP Asset Management first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Pfizer position peaked at $28.2M in Q1 2026.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.